SCHEMBL19418192

SCHEMBL19418192

CC(C)N(c1ccc(C#N)cn1)C(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
KDM4E B2RXH2 4/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
CYP19A1 P11511 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HRH4 Q9H3N8 2/20 0.35
CCNA2 P20248 1/20 0.35
CDK2 P24941 1/20 0.35
JAK3 P52333 3/20 0.34
JAK2 O60674 2/20 0.34
CYP2A6 P11509 1/20 0.34
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 2/20 0.34
HTT P42858 1/20 0.34
GPR119 Q8TDV5 1/20 0.34
AR P10275 3/20 0.33
EGLN2 Q96KS0 1/20 0.33
PANK3 Q9H999 1/20 0.33
PGR P06401 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2815513 0.84 ALDH1A1 (0.41) ALDH1A1KDM4EL3MBTL1CYP19A1HDAC6
SCHEMBL165008 0.79 ALDH1A1 (0.46) ALDH1A1KDM4EL3MBTL1CYP19A1CCNA2
SCHEMBL27306012 0.75 AR (0.52) ALDH1A1KDM4EL3MBTL1CYP19A1HDAC6
SCHEMBL19418347 0.75 ALDH1A1 (0.37) ALDH1A1KDM4EL3MBTL1CYP19A1HDAC6
SCHEMBL2816938 0.75 KDM4E (0.35) ALDH1A1KDM4EL3MBTL1CYP19A1HDAC6
SCHEMBL8750801 0.74 GBA1 (0.55) ALDH1A1KDM4EL3MBTL1CYP19A1HDAC6
SCHEMBL27306293 0.74 AR (0.40) ALDH1A1KDM4EL3MBTL1CYP19A1HDAC6
SCHEMBL31473419 0.74 AR (0.39) ALDH1A1KDM4EL3MBTL1CYP19A1HDAC6
SCHEMBL27297816 0.74 AR (0.39) ALDH1A1KDM4EL3MBTL1CYP19A1HDAC6
SCHEMBL19418041 0.73 KDM4E (0.42) ALDH1A1KDM4EL3MBTL1HDAC6JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2925757-B1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES NOVARTIS AG (CH) 2017-10-04 EP disclosed